-
乳腺癌是危害女性健康的主要恶性肿瘤,近年来乳腺癌的发病率明显上升,且发病年龄呈年轻化趋势,早期诊断是提高乳腺癌患者生存率、降低病死率的关键因素之一。随着功能影像的技术的发展,18F-FDG PET/CT与3.0T MRI在乳腺癌诊断中的价值越来越受到重视,且两种显像方法在乳腺癌原发病灶诊断中各具优势,本研究对38例临床高度怀疑为乳腺癌的患者于一周内分别行18F-FDG PET/CT、3.0T MRI和病理学检查,以探讨18F-FDG PET/CT与3.0T MRI联合显像在乳腺癌原发病灶诊断中的价值。
18F-FDG PET/CT与3.0T MRI联合显像在乳腺癌原发病灶诊断中的价值
Diagnosis value of 18F-FDG PET/CT and 3.0T MRI combined imaging in detecting the primary focus of breast cancer
-
摘要:
目的 探讨18F-FDG PET/CT与3.0T MRI联合显像在乳腺癌原发病灶诊断中的价值。 方法 对38例临床怀疑为乳腺癌的女性患者于一周内分别行18F-FDG PET/CT、3.0T MRI和病理学检查。 结果 组织病理学检查结果证实,全部患者中,24例为乳腺癌患者,14例为乳腺良性肿瘤患者。3.0T MRI诊断乳腺癌的灵敏度、特异度、准确率分别为91.7%、78.6%、86.8%;PET/CT诊断乳腺癌的灵敏度、特异度、准确率分别为87.5%、92.9%、89.5%;PET/CT和3.0T MR联合显像诊断乳腺癌的灵敏度、特异度、准确率分别为100.0%、92.9%、97.4%;3种显像方法间灵敏度、特异度、准确率差异无统计学意义(χ2=2.987、1.612和2.955,P均>0.05)。 结论 18F-FDG PET/CT和3.0T MRI联合显像在乳腺癌原发病灶诊断中具有重要价值;但与单独18F-FDG PET/CT和3.0T MRI显像比较,3种显像方法在乳腺癌原发病灶的诊断效能上差异无统计学意义。 -
关键词:
- 乳腺肿瘤 /
- 正电子发射断层显像术 /
- 体层摄影术,X线计算机 /
- 氟脱氧葡萄糖F18 /
- 磁共振成像
Abstract:Objective To explore the diagnosis value of 18F-FDG PET/CT and 3.0T MR combined imaging in detecting the primary focus of breast cancer. Methods Thirty eight female patients with highly suspected breast cancer were selected, 18F-FDG PET/CT and 3.0T MRI imaging were performed and their pathological results were gotten within 7 days. Results Twenty four malignant cases and 14 benign cases of the 38 patients were proved by pathology. The sensitivity, specificity and accuracy rate obtained by 3.0T MRI were 91.7%, 78.6% and 86.8%, respectively; they were 87.5%, 92.9% and 89.5% for 18F-FDG PET/CT; and which were 100.0%, 92.9% and 97.4% with 18F-FDG PET/CT and 3.0T MRI combined imaging. There were no significant difference among the three methods in the diagnostic ability(χ2=2.987, 1.612 and 2.955, all P > 0.05). Conclusions The combination of 18F-FDG PET/CT imaging and 3.0T MRI imaging in detecting the primary focus of breast cancer has important value, and comparison with separate 18F-FDG PET/CT imaging or 3.0T MRI imaging, the diagnosis efficiency of three imaging methods in breast cancer without statistics difference. -
[1] 余丰文, 冯彦林, 贺小红, 等. PET-CT与钼靶X线、B超定性诊断乳腺癌的临床对比研究.国际放射医学核医学杂志, 2006, 30(3): 148-151. doi: 10.3760/cma.j.issn.1673-4114.2006.03.007
[2] Wang Y, Yu J, Liu J, et al. PET-CT in the diagnosis of both primary breast cancer and axillary lymph node metastasis: initial experience. Int J Radiat Oncol Biol phys, 2003, 57(2 Suppl): S362-363. [3] Scheidhauer K, Walter C, Seemann MD. FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions. Eur J Nucl Med Mol Imaging, 2004, 31(1 Suppl): S70-79. [4] 赵桐, 王永胜, 杨国仁, 等. PET/CT在乳腺癌保乳微创治疗中的应用研究.肿瘤研究与临床, 2004, 16(2): 103-106. doi: 10.3760/cma.j.issn.1006-9801.2004.02.012
[5] 赵继红, 丁军, 徐松柏, 等. 18F-FDG PET/CT与MRI对乳腺癌诊断价值的比较.吉林大学学报:医学版, 2011, 37(4): 746-749.
[6] 唐立岷, 马超. 18F-FDG PET/CT在诊断浸润性乳腺癌和淋巴结转移中的价值.上海交通大学学报:医学版, 2012, 32(6): 761-765.
[7] Walter C, Scheidhauer K, Scharl A, et al. Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions. Eur Radiol, 2003, 13(7): 1651-1656. doi: 10.1007/s00330-002-1816-1 [8] Wahl RL, Siegel BA, Coleman RE, et al. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. J Clin Oncol, 2004, 22(2): 277-285. [9] 易梅, 程绍玲, 李冬梅.钼靶、MRI在乳腺癌诊断中的应用.中国医药导报, 2008, 5(8): 87. doi: 10.3969/j.issn.1673-7210.2008.08.060
[10] Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol, 2002, 179(1): 171-178. doi: 10.2214/ajr.179.1.1790171 [11] Al-Khawari H, Kovacs A, Athyal R, et al. Breast magnetic resonance imaging: initial experience in Kuwait. Med Princ Pract, 2009, 18(2): 143-148. doi: 10.1159/000189813